ID   UT-EC-1
AC   CVCL_X003
SY   University of Turku-Endometrial Carcinoma-1
DR   IARC_TP53; 21687
DR   Wikidata; Q54992042
RX   PubMed=1541432;
RX   PubMed=7798295;
RX   PubMed=9887230;
CC   Doubling time: 72 hours (PubMed=1541432).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
RX   PubMed=1541432; DOI=10.1016/0090-8258(92)90045-K;
RA   Rantanen V., Grenman S.E., Kulmala J., Salmi T., Grenman R.;
RT   "Radiation sensitivity of endometrial carcinoma in vitro.";
RL   Gynecol. Oncol. 44:217-222(1992).
//
RX   PubMed=7798295; DOI=10.1007/BF01194268;
RA   Rantanen V., Grenman S.E., Kulmala J., Alanen K., Lakkala T.,
RA   Grenman R.;
RT   "Sublethal damage repair after fractionated irradiation in endometrial
RT   cancer cell lines tested with the 96-well plate clonogenic assay.";
RL   J. Cancer Res. Clin. Oncol. 120:712-716(1994).
//
RX   PubMed=9887230; DOI=10.1006/gyno.1998.5194;
RA   Rantanen V., Grenman S.E., Kurvinen K., Hietanen S.H., Raitanen M.,
RA   Syrjanen S.M.;
RT   "p53 mutations and presence of HPV DNA do not correlate with
RT   radiosensitivity of gynecological cancer cell lines.";
RL   Gynecol. Oncol. 71:352-358(1998).
//